INRIG JULA (Chief Medical Officer) reported 1 transaction at TRAVERE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/22/2026ACC: 0001902368-26-000007
Officer· Chief Medical Officer
Since Jan 2022
-468.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
468.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−468.00
Price / share
—
Trade value
—
% of position
0.4%
6/22/2026
113.24K→112.77K
Total
Net shares
−468.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/22/2026 | G · Gift | −468.00 | — | — | 0.4% | 113.24K | 112.77K |
| Total | −468.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported